Among the most informative genes overexpressed in AML were known genes encoding cell surface proteins, e.g., CD33 and CD11c (currently ITGAX), and transcription factors, including HOXA9 oncogene, whose high expression level was noted in AML patients with poor outcome. The gene discussed is HOXA9; the disease is acute myeloid leukemia.